Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
    March 2021
  1. LEJA M, Kortelainen JM, Polaka I, Turppa E, et al
    Sensing gastric cancer via point-of-care sensor breath analyzer.
    Cancer. 2021 Mar 19. doi: 10.1002/cncr.33437.
    >> Share

    January 2021
  2. LI B, Cheung KS, Wong IY, Leung WK, et al
    Nonaspirin nonsteroidal anti-inflammatory drugs and gastric cancer risk after Helicobacter pylori eradication: A territory-wide study.
    Cancer. 2021 Jan 20. doi: 10.1002/cncr.33412.
    >> Share

    October 2020
  3. SETIA N, Wang CX, Lager A, Maron S, et al
    Morphologic and molecular analysis of early-onset gastric cancer.
    Cancer. 2020 Oct 13. doi: 10.1002/cncr.33213.
    >> Share

    June 2020

  4. The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases.
    Cancer. 2020;126:2541-2546.
    >> Share

    February 2020
  5. SUH YS, Lee J, Woo H, Shin D, et al
    National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost.
    Cancer. 2020 Feb 7. doi: 10.1002/cncr.32753.
    >> Share

    January 2020
  6. TIAN S, Jiang R, Madden NA, Ferris MJ, et al
    Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Cancer. 2020;126:37-45.
    >> Share

    December 2019
  7. THIELS CA, Hanson KT, Habermann EB, Boughey JC, et al
    Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.
    Cancer. 2019 Dec 10. doi: 10.1002/cncr.32660.
    >> Share

    July 2019
  8. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    >> Share

  9. CLEARY JM, Horick NK, McCleary NJ, Abrams TA, et al
    FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
    Cancer. 2019;125:2213-2221.
    >> Share

    June 2019
  10. GREALLY M, Agarwal R, Ilson DH
    Optimal management of gastroesophageal junction cancer.
    Cancer. 2019;125:1990-2001.
    >> Share

    May 2019
  11. SHARMA MR, Joshi SS, Karrison TG, Allen K, et al
    A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
    Cancer. 2019;125:1629-1636.
    >> Share

    April 2019
  12. MA G, Liu H, Du M, Zhang G, et al
    A genetic variation in the CpG island of pseudogene GBAP1 promoter is associated with gastric cancer susceptibility.
    Cancer. 2019 Apr 5. doi: 10.1002/cncr.32081.
    >> Share

    March 2019
  13. HUANG J, Mo H, Zhang W, Chen X, et al
    Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China.
    Cancer. 2019;125:742-749.
    >> Share

    January 2019
  14. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.
    >> Share

    February 2018
  15. IKOMA N, Cormier JN, Feig B, Du XL, et al
    Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.
    Cancer. 2018 Feb 2. doi: 10.1002/cncr.31155.
    >> Share

    January 2018
  16. NEUWIRTH MG, Bierema C, Sinnamon AJ, Fraker DL, et al
    Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?
    Cancer. 2018;124:125-135.
    >> Share

    December 2017
  17. JIM MA, Pinheiro PS, Carreira H, Espey DK, et al
    Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:4994-5013.
    >> Share

  18. MOKDAD AA, Ali A, Yopp AC, Polanco PM, et al
    Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31179.
    >> Share

  19. WANG P, Sun Z, Wang W, Deng J, et al
    Conditional survival of patients with gastric cancer who undergo curative resection: A multi-institutional analysis in China.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31160.
    >> Share

    October 2017
  20. LEVI Z, Kark JD, Twig G, Katz L, et al
    Body mass index at adolescence and risk of noncardia gastric cancer in a cohort of 1.79 million men and women.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31049.
    >> Share

  21. STUMPF PK, Amini A, Jones BL, Koshy M, et al
    Reply to Tumor localization may change the type of adjuvant treatment in gastric cancer.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31018.
    >> Share

  22. TEZ M, Altundag K
    Tumor localization may change the type of adjuvant treatment in gastric cancer.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31021.
    >> Share

    September 2017
  23. STUMPF PK, Amini A, Jones BL, Koshy M, et al
    Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
    Cancer. 2017;123:3402-3409.
    >> Share

    August 2017
  24. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    >> Share

  25. MASTELLARO MJ, Seidinger AL, Kang G, Abrahao R, et al
    Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
    Cancer. 2017;123:3150-3158.
    >> Share

  26. FITZGERALD TL, Efird JT, Bellamy N, Russo SM, et al
    Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.
    Cancer. 2017;123:2909-2917.
    >> Share

    May 2017
  27. CATENACCI DV, Ang A, Liao WL, Shen J, et al
    MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Cancer. 2017;123:1061-1070.
    >> Share

    March 2017
  28. STIEKEMA A, Van de Vijver KK, Boot H, Broeks A, et al
    Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Mullerian origin from gastrointestinal cancer.
    Cancer. 2017;125:197-204.
    >> Share

    January 2017
  29. BEKAII-SAAB T, El-Rayes B
    Identifying and targeting cancer stem cells in the treatment of gastric cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30538.
    >> Share

  30. PRINTZ C
    Cancer mortality rates vary among specific Asian American ethnic groups.
    Cancer. 2017;123:11.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016